Novo Nordisk
fulcrumsecThis record tracks a ransomware attack claimed by the fulcrumsec group against Novo Nordisk. It collects the publicly disclosed attack details — sector, location and timeline — as published on the operator's leak site and indexed by Breach House.
Window Zero
EXPOSURE GAPWindow Zero is the time the breach stayed in the open before anyone said so — the gap between when the attack was first discovered on the operator's leak site (t1) and when it was publicly disclosed (t2). The wider this window, the longer victims, staff and customers were exposed with no warning.
Attack Summary
[AI generated] Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, it specializes in treatments for diabetes, obesity, hemophilia, and other chronic conditions. The company is a global leader in insulin production and develops drugs such as semaglutide. It operates in over 80 countries and is one of Europe's most valuable corporations by market capitalization.
Leak Screenshots
SAMPLEProof-of-breach screenshots the operator posted from the stolen data. Previews are redacted and locked — the originals are available on HaveIBeenRansom.